These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 24480931)

  • 41. Temporal and region-dependent changes in muscarinic M4 receptors in the hippocampus and entorhinal cortex of adrenalectomized rats.
    Mulugeta E; Chandranath I; Karlsson E; Winblad B; Adem A
    Exp Brain Res; 2006 Aug; 173(2):309-17. PubMed ID: 16676164
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparative behavioral and neurochemical activities of cholinergic antagonists in rats.
    Bymaster FP; Heath I; Hendrix JC; Shannon HE
    J Pharmacol Exp Ther; 1993 Oct; 267(1):16-24. PubMed ID: 7901390
    [TBL] [Abstract][Full Text] [Related]  

  • 43. State-dependent alterations in sleep/wake architecture elicited by the M4 PAM VU0467154 - Relation to antipsychotic-like drug effects.
    Gould RW; Nedelcovych MT; Gong X; Tsai E; Bubser M; Bridges TM; Wood MR; Duggan ME; Brandon NJ; Dunlop J; Wood MW; Ivarsson M; Noetzel MJ; Daniels JS; Niswender CM; Lindsley CW; Conn PJ; Jones CK
    Neuropharmacology; 2016 Mar; 102():244-53. PubMed ID: 26617071
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Selective labeling and localization of the M4 (m4) muscarinic receptor subtype.
    Ferrari-Dileo G; Waelbroeck M; Mash DC; Flynn DD
    Mol Pharmacol; 1994 Dec; 46(6):1028-35. PubMed ID: 7808421
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The M4 muscarinic antagonist MT-3 inhibits myopia in chick: evidence for site of action.
    McBrien NA; Arumugam B; Gentle A; Chow A; Sahebjada S
    Ophthalmic Physiol Opt; 2011 Sep; 31(5):529-39. PubMed ID: 21539592
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antipsychotic-like Effects of M4 Positive Allosteric Modulators Are Mediated by CB2 Receptor-Dependent Inhibition of Dopamine Release.
    Foster DJ; Wilson JM; Remke DH; Mahmood MS; Uddin MJ; Wess J; Patel S; Marnett LJ; Niswender CM; Jones CK; Xiang Z; Lindsley CW; Rook JM; Conn PJ
    Neuron; 2016 Sep; 91(6):1244-1252. PubMed ID: 27618677
    [TBL] [Abstract][Full Text] [Related]  

  • 47. M2, M3 and M4, but not M1, muscarinic receptor subtypes are present in rat spinal cord.
    Höglund AU; Baghdoyan HA
    J Pharmacol Exp Ther; 1997 Apr; 281(1):470-7. PubMed ID: 9103533
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of various subtypes of muscarinic cholinergic receptors in the development of posthemorrhagic abnormalities in systemic and portal circulation in rats.
    Kovalenko NY; Matsievskii DD; Reshetnyak VK
    Bull Exp Biol Med; 2012 Jan; 152(3):293-7. PubMed ID: 22803069
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Roles of M2 and M4 muscarinic receptors in regulating acetylcholine release from myenteric neurons of mouse ileum.
    Takeuchi T; Fujinami K; Goto H; Fujita A; Taketo MM; Manabe T; Matsui M; Hata F
    J Neurophysiol; 2005 May; 93(5):2841-8. PubMed ID: 15574798
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synthesis and pharmacological profiling of analogues of benzyl quinolone carboxylic acid (BQCA) as allosteric modulators of the M1 muscarinic receptor.
    Mistry SN; Valant C; Sexton PM; Capuano B; Christopoulos A; Scammells PJ
    J Med Chem; 2013 Jun; 56(12):5151-72. PubMed ID: 23718562
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Memory-related task performance by aged rhesus monkeys administered the muscarinic M(1)-preferring agonist, talsaclidine.
    Terry AV; Buccafusco JJ; Borsini F; Leusch A
    Psychopharmacology (Berl); 2002 Jul; 162(3):292-300. PubMed ID: 12122487
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In Vivo Modulation of Hippocampal Excitability by M4 Muscarinic Acetylcholine Receptor Activator: Implications for Treatment of Alzheimer's Disease and Schizophrenic Patients.
    Popiolek M; Mandelblat-Cerf Y; Young D; Garst-Orozco J; Lotarski SM; Stark E; Kramer M; Butler CR; Kozak R
    ACS Chem Neurosci; 2019 Mar; 10(3):1091-1098. PubMed ID: 30335349
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Interaction of neuromuscular blocking drugs with recombinant human m1-m5 muscarinic receptors expressed in Chinese hamster ovary cells.
    Cembala TM; Sherwin JD; Tidmarsh MD; Appadu BL; Lambert DG
    Br J Pharmacol; 1998 Nov; 125(5):1088-94. PubMed ID: 9846649
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Serotonergic-Muscarinic Interaction within the Prefrontal Cortex as a Novel Target to Reverse Schizophrenia-Related Cognitive Symptoms.
    Cieślik P; Radulska A; Burnat G; Kalinowski L; Wierońska JM
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445318
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Selectivity profile of muscarinic toxin 3 in functional assays of cloned and native receptors.
    Olianas MC; Ingianni A; Maullu C; Adem A; Karlsson E; Onali P
    J Pharmacol Exp Ther; 1999 Jan; 288(1):164-70. PubMed ID: 9862767
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of acute and repeated administration of the selective M
    Thomsen M; Crittenden JR; Lindsley CW; Graybiel AM
    Addict Biol; 2022 Mar; 27(2):e13145. PubMed ID: 35229940
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Neuronal nitric oxide synthase activity in rat urinary bladder detrusor: participation in M3 and M4 muscarinic receptor function.
    Orman B; Sterin-Borda L; Reina S; Borda ES
    Auton Autacoid Pharmacol; 2005 Jul; 25(3):93-100. PubMed ID: 15955028
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Universal template approach to drug design: polyamines as selective muscarinic receptor antagonists.
    Bolognesi ML; Minarini A; Budriesi R; Cacciaguerra S; Chiarini A; Spampinato S; Tumiatti V; Melchiorre C
    J Med Chem; 1998 Oct; 41(21):4150-60. PubMed ID: 9767650
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Muscarinic M1, but not M4, receptor antagonism impairs divided attention in male rats.
    Nicklas PR; Kiefer ML; Whalen MA; Stewart MT; Mosura DE; Bennett EM; Hawley WR; McLaughlin PJ
    Pharmacol Biochem Behav; 2021 Jun; 205():173184. PubMed ID: 33836220
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.